Japan Varicella Attenuated Live Vaccine Market Report 2016

October 2016 | 117 pages | ID: JBFC5D30E21EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Varicella Attenuated Live Vaccine

Revenue, means the sales value of Varicella Attenuated Live Vaccine

This report studies sales (consumption) of Varicella Attenuated Live Vaccine in Japan market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• GSK
• Merck
• Beijing Tiantan Biological Products
• Chengdu Institute of Biological Products
• Shanghai Institute of Biological Products
• Changchun Keygen Biological Products
• Changsheng

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Varicella Attenuated Live Vaccine in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Japan Varicella Attenuated Live Vaccine Market Report 2016

1 VARICELLA ATTENUATED LIVE VACCINE OVERVIEW

1.1 Product Overview and Scope of Varicella Attenuated Live Vaccine
1.2 Classification of Varicella Attenuated Live Vaccine
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Varicella Attenuated Live Vaccine
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Japan Market Size Sales (Value) and Revenue (Volume) of Varicella Attenuated Live Vaccine (2011-2021)
  1.4.1 Japan Varicella Attenuated Live Vaccine Sales and Growth Rate (2011-2021)
  1.4.2 Japan Varicella Attenuated Live Vaccine Revenue and Growth Rate (2011-2021)

2 JAPAN VARICELLA ATTENUATED LIVE VACCINE COMPETITION BY MANUFACTURERS

2.1 Japan Varicella Attenuated Live Vaccine Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 Japan Varicella Attenuated Live Vaccine Revenue and Share by Manufactures (2015 and 2016)
2.3 Japan Varicella Attenuated Live Vaccine Average Price by Manufactures (2015 and 2016)
2.4 Varicella Attenuated Live Vaccine Market Competitive Situation and Trends
  2.4.1 Varicella Attenuated Live Vaccine Market Concentration Rate
  2.4.2 Varicella Attenuated Live Vaccine Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 JAPAN VARICELLA ATTENUATED LIVE VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 Japan Varicella Attenuated Live Vaccine Sales and Market Share by Type (2011-2016)
3.2 Japan Varicella Attenuated Live Vaccine Revenue and Market Share by Type (2011-2016)
3.3 Japan Varicella Attenuated Live Vaccine Price by Type (2011-2016)
3.4 Japan Varicella Attenuated Live Vaccine Sales Growth Rate by Type (2011-2016)

4 JAPAN VARICELLA ATTENUATED LIVE VACCINE SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 Japan Varicella Attenuated Live Vaccine Sales and Market Share by Application (2011-2016)
4.2 Japan Varicella Attenuated Live Vaccine Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 JAPAN VARICELLA ATTENUATED LIVE VACCINE MANUFACTURERS PROFILES/ANALYSIS

5.1 GSK
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Varicella Attenuated Live Vaccine Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 GSK Varicella Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Merck
  5.2.2 Varicella Attenuated Live Vaccine Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Merck Varicella Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Beijing Tiantan Biological Products
  5.3.2 Varicella Attenuated Live Vaccine Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Beijing Tiantan Biological Products Varicella Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Chengdu Institute of Biological Products
  5.4.2 Varicella Attenuated Live Vaccine Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Chengdu Institute of Biological Products Varicella Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Shanghai Institute of Biological Products
  5.5.2 Varicella Attenuated Live Vaccine Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Shanghai Institute of Biological Products Varicella Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Changchun Keygen Biological Products
  5.6.2 Varicella Attenuated Live Vaccine Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Changchun Keygen Biological Products Varicella Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Changsheng
  5.7.2 Varicella Attenuated Live Vaccine Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Changsheng Varicella Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview

6 VARICELLA ATTENUATED LIVE VACCINE MANUFACTURING COST ANALYSIS

6.1 Varicella Attenuated Live Vaccine Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Varicella Attenuated Live Vaccine

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Varicella Attenuated Live Vaccine Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Varicella Attenuated Live Vaccine Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 JAPAN VARICELLA ATTENUATED LIVE VACCINE MARKET FORECAST (2016-2021)

10.1 Japan Varicella Attenuated Live Vaccine Sales, Revenue Forecast (2016-2021)
10.2 Japan Varicella Attenuated Live Vaccine Sales Forecast by Type (2016-2021)
10.3 Japan Varicella Attenuated Live Vaccine Sales Forecast by Application (2016-2021)
10.4 Varicella Attenuated Live Vaccine Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Varicella Attenuated Live Vaccine
Table Classification of Varicella Attenuated Live Vaccine
Figure Japan Sales Market Share of Varicella Attenuated Live Vaccine by Type in 2015
Table Application of Varicella Attenuated Live Vaccine
Figure Japan Sales Market Share of Varicella Attenuated Live Vaccine by Application in 2015
Figure Japan Varicella Attenuated Live Vaccine Sales and Growth Rate (2011-2021)
Figure Japan Varicella Attenuated Live Vaccine Revenue and Growth Rate (2011-2021)
Table Japan Varicella Attenuated Live Vaccine Sales of Key Manufacturers (2015 and 2016)
Table Japan Varicella Attenuated Live Vaccine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Varicella Attenuated Live Vaccine Sales Share by Manufacturers
Figure 2016 Varicella Attenuated Live Vaccine Sales Share by Manufacturers
Table Japan Varicella Attenuated Live Vaccine Revenue by Manufacturers (2015 and 2016)
Table Japan Varicella Attenuated Live Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Japan Varicella Attenuated Live Vaccine Revenue Share by Manufacturers
Table 2016 Japan Varicella Attenuated Live Vaccine Revenue Share by Manufacturers
Table Japan Market Varicella Attenuated Live Vaccine Average Price of Key Manufacturers (2015 and 2016)
Figure Japan Market Varicella Attenuated Live Vaccine Average Price of Key Manufacturers in 2015
Figure Varicella Attenuated Live Vaccine Market Share of Top 3 Manufacturers
Figure Varicella Attenuated Live Vaccine Market Share of Top 5 Manufacturers
Table Japan Varicella Attenuated Live Vaccine Sales by Type (2011-2016)
Table Japan Varicella Attenuated Live Vaccine Sales Share by Type (2011-2016)
Figure Japan Varicella Attenuated Live Vaccine Sales Market Share by Type in 2015
Table Japan Varicella Attenuated Live Vaccine Revenue and Market Share by Type (2011-2016)
Table Japan Varicella Attenuated Live Vaccine Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Varicella Attenuated Live Vaccine by Type (2011-2016)
Table Japan Varicella Attenuated Live Vaccine Price by Type (2011-2016)
Figure Japan Varicella Attenuated Live Vaccine Sales Growth Rate by Type (2011-2016)
Table Japan Varicella Attenuated Live Vaccine Sales by Application (2011-2016)
Table Japan Varicella Attenuated Live Vaccine Sales Market Share by Application (2011-2016)
Figure Japan Varicella Attenuated Live Vaccine Sales Market Share by Application in 2015
Table Japan Varicella Attenuated Live Vaccine Sales Growth Rate by Application (2011-2016)
Figure Japan Varicella Attenuated Live Vaccine Sales Growth Rate by Application (2011-2016)
Table GSK Basic Information List
Table GSK Varicella Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GSK Varicella Attenuated Live Vaccine Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Varicella Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Varicella Attenuated Live Vaccine Sales Market Share (2011-2016)
Table Beijing Tiantan Biological Products Basic Information List
Table Beijing Tiantan Biological Products Varicella Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Beijing Tiantan Biological Products Varicella Attenuated Live Vaccine Sales Market Share (2011-2016)
Table Chengdu Institute of Biological Products Basic Information List
Table Chengdu Institute of Biological Products Varicella Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Chengdu Institute of Biological Products Varicella Attenuated Live Vaccine Sales Market Share (2011-2016)
Table Shanghai Institute of Biological Products Basic Information List
Table Shanghai Institute of Biological Products Varicella Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shanghai Institute of Biological Products Varicella Attenuated Live Vaccine Sales Market Share (2011-2016)
Table Changchun Keygen Biological Products Basic Information List
Table Changchun Keygen Biological Products Varicella Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Changchun Keygen Biological Products Varicella Attenuated Live Vaccine Sales Market Share (2011-2016)
Table Changsheng Basic Information List
Table Changsheng Varicella Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Changsheng Varicella Attenuated Live Vaccine Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Varicella Attenuated Live Vaccine
Figure Manufacturing Process Analysis of Varicella Attenuated Live Vaccine
Figure Varicella Attenuated Live Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Varicella Attenuated Live Vaccine Major Manufacturers in 2015
Table Major Buyers of Varicella Attenuated Live Vaccine
Table Distributors/Traders List
Figure Japan Varicella Attenuated Live Vaccine Production and Growth Rate Forecast (2016-2021)
Figure Japan Varicella Attenuated Live Vaccine Revenue and Growth Rate Forecast (2016-2021)
Table Japan Varicella Attenuated Live Vaccine Production Forecast by Type (2016-2021)
Table Japan Varicella Attenuated Live Vaccine Consumption Forecast by Application (2016-2021)